Clinical Trials Browser

FEC protocol × Clear all

NCT00131612 2016-02-26

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

Breast Neoplasms

NCT02225652 2014-08-26

A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.

Phase 2 Completed

Women With Primary Breast Cancer